These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7555190)

  • 21. [Intensity of oral anticoagulant therapy after heart valve replacement].
    Stenzinger W
    Z Kardiol; 1998; 87 Suppl 4():37-41. PubMed ID: 9857465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventing thromboembolism in patients with prosthetic heart valves.
    Turpie AG
    Cardiol Clin; 1994 Aug; 12(3):487-93. PubMed ID: 7805081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of mechanical heart valve thrombosis through a clinical audit.
    Bharat V; Das NK; Mohanty B; Jha AC; Chawla SC; Dash B; Mohanty R
    J Heart Valve Dis; 2003 May; 12(3):362-9. PubMed ID: 12803337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pregnancy and the mechanical prosthetic valve: dilemmas about the choice of antithrombotic prophylaxis].
    Roos-Hesselink JW; Meijboom FJ; Leebeek FW; de Groot CJ
    Ned Tijdschr Geneeskd; 2007 Feb; 151(7):389-94. PubMed ID: 17343136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valvular Heart Disease in Adults: Management of Prosthetic Heart Valves.
    Trujillo JF; Hollenberg SM
    FP Essent; 2017 Jun; 457():23-29. PubMed ID: 28671806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The net clinical benefit of the antithrombotic protection in prosthetic mechanical valves: Changing the paradigm.
    Dan GA
    Int J Cardiol; 2018 Sep; 267():77-78. PubMed ID: 29884289
    [No Abstract]   [Full Text] [Related]  

  • 27. Do all patients with mechanical heart valve prostheses need anticoagulant therapy?
    Dale J; Nitter-Hauge S
    Z Kardiol; 1986; 75 Suppl 2():332-7. PubMed ID: 3727714
    [No Abstract]   [Full Text] [Related]  

  • 28. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
    Goldsmith I; Lip GY; Mukundan S; Rosin MD
    J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement in Elderly Patients: A Single-Center Experience.
    Lee SI; Lee KS; Kim JB; Choo SJ; Chung CH; Lee JW; Jung SH
    Ann Thorac Cardiovasc Surg; 2017 Jun; 23(3):128-134. PubMed ID: 28367855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombo-embolic prevention after transcatheter aortic valve implantation.
    Vranckx P; Windecker S; Welsh RC; Valgimigli M; Mehran R; Dangas G
    Eur Heart J; 2017 Dec; 38(45):3341-3350. PubMed ID: 29020333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Surgery of the patients on anticoagulants following prosthetic valve replacement].
    Kosuga K; Aoyagi S; Shima H; Yanagi I; Oryoji A; Oishi K; Koga M
    Nihon Geka Gakkai Zasshi; 1987 Jun; 88(6):779-84. PubMed ID: 3627099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The optimal therapeutic range for oral anticoagulant treatment as suggested by fibrinopeptide A (FpA) levels in patients with heart valve prostheses.
    Pengo V; Peruzzi P; Baca M; Marzari A; Zanon F; Schivapappa L; Dalla Volta S
    Eur J Clin Invest; 1989 Apr; 19(2):181-4. PubMed ID: 2499477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticoagulation After Heart Valve Replacement or Transcatheter Valve Implantation.
    Carnicelli AP; O'Gara PT; Giugliano RP
    Am J Cardiol; 2016 Nov; 118(9):1419-1426. PubMed ID: 27666180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Endoscopy in patients receiving anticoagulation therapy II].
    Bovin A
    Ugeskr Laeger; 2009 Aug; 171(33):2330; author reply 2330. PubMed ID: 19743530
    [No Abstract]   [Full Text] [Related]  

  • 35. Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis. The Loire Valley Atrial Fibrillation Project.
    Philippart R; Brunet-Bernard A; Clementy N; Bourguignon T; Mirza A; Angoulvant D; Babuty D; Lip GY; Fauchier L
    Thromb Haemost; 2016 May; 115(5):1056-63. PubMed ID: 26843425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current recommendations for prevention of thromboembolism in patients with heart valve prostheses].
    Gohlke-Bärwolf C
    Z Kardiol; 2001; 90 Suppl 6():112-7. PubMed ID: 11826813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Followup of patients with heart valves].
    Vermes E
    Rev Prat; 2002 Apr; 52(7):765-9. PubMed ID: 12032964
    [No Abstract]   [Full Text] [Related]  

  • 38. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antithrombotic therapy following heart valve replacement.
    Turpie AG
    Thromb Haemost; 1997 Jul; 78(1):382-5. PubMed ID: 9198183
    [No Abstract]   [Full Text] [Related]  

  • 40. [Valvular prosthesis: indications and updated protocols for thrombosis prophylaxis].
    Dalla Volta S
    Cardiologia; 1994 Dec; 39(12 Suppl 1):331-40. PubMed ID: 7634293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.